Baldacci, S., Mazieres, J., Tomasini, P., Girard, N., Guisier, F., Audigier-Valette, C., . . . Cortot, A. B. (2017). Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors. Oncotarget.
Chicago ZitierstilBaldacci, Simon, et al. "Outcome of EGFR-mutated NSCLC Patients With MET-driven Resistance to EGFR Tyrosine Kinase Inhibitors." Oncotarget 2017.
MLA ZitierstilBaldacci, Simon, et al. "Outcome of EGFR-mutated NSCLC Patients With MET-driven Resistance to EGFR Tyrosine Kinase Inhibitors." Oncotarget 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.